SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

Inogen Sees Prelim. Q4 Sales $78.4M-$79.4M vs $89.96M Est., Prelim. FY19 Sales $361.4M-$362.4M vs $372.96M Est; Sees FY20 Sales $385M-$400M vs $411.23M Est.

Benzinga · -